Cell‐free next‐generation sequencing impacts diagnosis and antimicrobial therapy in immunocompromised hosts: A retrospective study
Sign Up to like & getrecommendations! Published in 2023 at "Transplant Infectious Disease"
DOI: 10.1111/tid.13954
Abstract: Cell‐free next‐generation sequencing (cfNGS) may have a unique role in the diagnosis of infectious complications in immunocompromised hosts. The rapid turnaround time and non‐invasive nature make it a promising supplement to standard of care. read more here.
Keywords: cell free; free next; next generation; immunocompromised hosts ... See more keywords